Thompson, P. A., O’Brien, S. M., Wierda, W. G., Ferrajoli, A., Stingo, F., Smith, S. C., . . . Keating, M. J. (2015). Complex Karyotype is a Stronger Predictor than Del(17p) for Inferior Outcome in Relapsed or Refractory CLL Patients Treated with Ibrutinib-Based Regimens. Cancer.

Thompson, Philip A., et al. "Complex Karyotype Is a Stronger Predictor Than Del(17p) for Inferior Outcome in Relapsed or Refractory CLL Patients Treated With Ibrutinib-Based Regimens." Cancer 2015.

Thompson, Philip A., et al. "Complex Karyotype Is a Stronger Predictor Than Del(17p) for Inferior Outcome in Relapsed or Refractory CLL Patients Treated With Ibrutinib-Based Regimens." Cancer 2015.